Rasonque
PulseAugur coverage of Rasonque — every cluster mentioning Rasonque across labs, papers, and developer communities, ranked by signal.
- 2026-08-26 product_launch The FDA approved Rasonque, a new pancreatic cancer drug developed by Revolution Medicines. source
-
US Healthcare Paradox: Medical Advances Outpace Patient Access
RevMed's Rasonque highlights a growing paradox in the US healthcare system where significant medical advancements are being made, yet increasing numbers of patients are unable to access these new products. This situatio…
-
Pancreatic Cancer Drug Rasonque's Price Sparks Sustainability Concerns
The high price of the pancreatic cancer drug Rasonque raises concerns about the long-term sustainability of drug pricing in the healthcare industry. As similar or more expensive cancer treatments are expected to launch …
-
FDA approves Revolution Medicines' pancreatic cancer pill Rasonque
The FDA has approved Rasonque, a new daily pill from Revolution Medicines, designed to target RAS protein mutations that drive tumor growth in pancreatic cancer. This approval marks a significant breakthrough, as it val…
-
FDA approves new pancreatic cancer drug daraxonrasib after trial success
The U.S. FDA has approved daraxonrasib (Rasonque), a new targeted therapy for pancreatic ductal adenocarcinoma (PDAC) in adults whose disease has spread and failed other treatments. This marks a significant advancement …